News | Proton Therapy | October 23, 2020

IBA Highlights the Future of Proton Therapy Technologies at ASTRO 2020

IBA showcases how its Proteus solutions and its network of clinical and industrial partners are shaping the future of proton therapy

IBA showcases how its Proteus solutions and its network of clinical and industrial partners are shaping the future of proton therapy

October 23, 2020 — IBA, a leading provider of proton therapy solutions, will highlight how its Proteus solutions as well as its work with its partners are shaping the future of proton therapy during the Annual Meeting and exhibition of the American Society for Radiation Oncology (ASTRO) being held online October 22-29, 2020.
 
IBA is displaying the latest developments for its Proteus systems that will address the current and future needs of proton therapy centers. IBA’s comprehensive Motion Management package will help clinicians treat more indications more confidently. Additionally, IBA’s unique Proton Arc Therapy will enable clinicians to treat patients precisely, faster and more easily. Finally, IBA believes Flash Therapy using protons has the potential to radically change the radiation therapy landscape revolutionize cancer care in general.
 
With 59 centers sold and 36 centers treating patients on a daily basis, IBA has the largest and most knowledgeable proton therapy user community. Together with its clinical partners, IBA is proud to celebrate a truly significant milestone of over 100,000 patients treated on an IBA Proteus system. This unique accumulated technical and clinical expertise is openly shared within IBA’s network of users through regular user meetings, bringing together experienced users as well as new members in the IBA community.
 
Having an open vendor platform, IBA also integrates the solutions of key leading industrial partners to further improve clinical workflow, integration and the overall user experience.  
 
IBA has a long-term collaboration with Philips in imaging, diagnostics and radiation therapy for comprehensive cancer treatment.
 
The long-standing collaboration with Elekta is allowing both companies to offer a full set of treatment modalities in radiation therapy. IBA is very excited about the upcoming innovations in the Elekta Treatment Planning Solution. Together with MOSAIQ OIS and MOSAIQ Plaza, this complete solution will provide a strong ecosystem to integrate Proton Therapy into radiation therapy departments. Close collaboration with RaySearch Laboratories has demonstrates a fully integrated proton therapy workflow integrating IBA’s Proteus solution with Advanced treatment planning system (TPS) RayStation and next-generation oncology information system (OIS) RayCare an at the University hospital of Leuven in Belgium, where patient treatments began in July.
 
Olivier Legrain, Chief Executive Officer of IBA commented: “We are immensely proud that IBA’s technology has now impacted over 100,000 lives, giving patients and their families a new hope for the future. We continue to pursue further innovation by developing new technologies that will allow us to provide increasingly high standards while reducing treatment costs. Our philosophy of openly sharing our technological expertise with our clinical and industrial partners makes us uniquely positioned to speed up the development and shape the future of proton therapy.”

For more information: www.iba-worldwide.com

Related Content

The 15-ton compact accelerator is lifted into the David C. Pratt Cancer Center at Mercy St. Louis. (Photo: Business Wire)

The 15-ton compact accelerator is lifted into the David C. Pratt Cancer Center at Mercy St. Louis. (Photo: Business Wire)

News | Radiation Oncology | July 21, 2021
July 23, 2021 — Mevion Medical Systems announced that it has delivered the 15-ton compact accelerator to...
ASTRO just issued the following statement in response to the Radiation Oncology Model update in yesterday's HOPPS proposed rule, which compounds significant and detrimental cuts to the cancer care specialty in the proposed 2022 MPFS

Getty Images

News | Radiation Therapy | July 20, 2021
July 20, 2021 — In response to consecutive weeks of proposed...
Artificial intelligence-powered diagnostic tool spots asymptomatic prostate cancer in seconds

(L-R) Associate Professor Peter Brotchie (St Vincent's), Dr Ruwan Tennakoon (RMIT), Professor John Thangarajah (RMIT), Dr Mark Page (St Vincent's). Image courtesy of St Vincent's Hospital Melbourne

News | Prostate Cancer | July 19, 2021
July 19, 2021 — Prostate cancer is the most diagnosed
Ramon Alfredo Siochi, Ph.D. — the director of medical physics at WVU — led a task group to help ensure the accuracy of data that dictates a cancer patient's radiation therapy.

Ramon Alfredo Siochi, director of medical physics at West Virginia University. Image courtesy of WVU Photo/Aira Burkhart

News | Radiation Oncology | July 15, 2021
July 15, 2021 — Just as helicopter traffic reporters use their "bird's eye view" to route drivers around roadblocks s
NeuroLogica joins forces with Massachusetts General Hospital to pilot OmniTom Elite with Photon Counting Detector (PCD) technology at patient point-of-care

NeuroLogica joins forces with Massachusetts General Hospital to pilot OmniTom Elite with Photon Counting Detector (PCD) technology at patient point-of-care. (Photo: Business Wire)

News | Computed Tomography (CT) | July 13, 2021
July 13, 2021 — NeuroLogica Corp.
 The numbers of cancer screening tests rebounded sharply in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic, at one large hospital system in the Northeastern United States. These findings were released in a study published in Cancer Cell. The research also found an increase in racial and socioeconomic disparities among users of some screening tests during the pandemic.

Getty Images

News | Radiation Oncology | July 12, 2021
July 12, 2021 — The numbers of...
To help enhance the images and information provided to clinicians for radiation oncology treatment planning, GE Healthcare will integrate Spectronic Medical’s AI-based software with its industry leading AIR Recon DL technology
News | Artificial Intelligence | July 09, 2021
July 9, 2021 — GE Healthcare announced the integration of S...
American Society for Radiation Oncology (ASTRO) to host in-person Annual Meeting in Chicago, October 24-27

Getty Images

News | ASTRO | July 08, 2021
July 8, 2021 — Registration opens today for the American Society for Radiation Oncology's (...